JP2023511376A5 - - Google Patents
Info
- Publication number
- JP2023511376A5 JP2023511376A5 JP2022544309A JP2022544309A JP2023511376A5 JP 2023511376 A5 JP2023511376 A5 JP 2023511376A5 JP 2022544309 A JP2022544309 A JP 2022544309A JP 2022544309 A JP2022544309 A JP 2022544309A JP 2023511376 A5 JP2023511376 A5 JP 2023511376A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- substitutions
- heterodimer protein
- protein according
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025114854A JP2025160226A (ja) | 2020-01-23 | 2025-07-08 | Fc変異を有するヘテロダイマータンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020073960 | 2020-01-23 | ||
| CNPCT/CN2020/073960 | 2020-01-23 | ||
| PCT/CN2021/073347 WO2021148006A1 (en) | 2020-01-23 | 2021-01-22 | Heterodimeric proteins with fc mutations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025114854A Division JP2025160226A (ja) | 2020-01-23 | 2025-07-08 | Fc変異を有するヘテロダイマータンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023511376A JP2023511376A (ja) | 2023-03-17 |
| JP2023511376A5 true JP2023511376A5 (cg-RX-API-DMAC7.html) | 2025-04-21 |
| JP7710450B2 JP7710450B2 (ja) | 2025-07-18 |
Family
ID=76992067
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544309A Active JP7710450B2 (ja) | 2020-01-23 | 2021-01-22 | Fc変異を有するヘテロダイマータンパク質 |
| JP2025114854A Pending JP2025160226A (ja) | 2020-01-23 | 2025-07-08 | Fc変異を有するヘテロダイマータンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025114854A Pending JP2025160226A (ja) | 2020-01-23 | 2025-07-08 | Fc変異を有するヘテロダイマータンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230124669A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4093778A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7710450B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220145833A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115279796A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021210482A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022014574A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3165045A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL294878A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022009101A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI920054B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021148006A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023549157A (ja) * | 2020-11-10 | 2023-11-22 | リビジェン バイオファーマ ホールディングス リミテッド | 抗cd137結合分子を含む二重特異性抗体 |
| WO2022170619A1 (en) * | 2021-02-11 | 2022-08-18 | Adagene Pte. Ltd. | Anti-cd3 antibodies and methods of use thereof |
| CN118339188A (zh) | 2021-09-21 | 2024-07-12 | 齐鲁普吉湾生物治疗公司 | 用于制备融合蛋白和双特异性抗体的异二聚体Fc |
| EP4496816A1 (en) * | 2022-03-23 | 2025-01-29 | CytomX Therapeutics, Inc. | Activatable antigen-binding protein constructs and uses of the same |
| WO2023193239A1 (en) | 2022-04-08 | 2023-10-12 | Peter Peizhi Luo | Anti-cd28 antibodies and methods of use thereof |
| CN116724057A (zh) * | 2022-11-28 | 2023-09-08 | 浙江时迈药业有限公司 | 蛋白酶可切割的重组双特异性抗体和组合物及其用途 |
| JP2026524012A (ja) * | 2023-07-10 | 2026-07-16 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 二重特異性pd-l1×4-1bb抗体およびそれらの使用方法 |
| KR20260115642A (ko) * | 2023-11-20 | 2026-07-24 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 재조합 반응을 통해 이종다량체를 제조하는 방법 |
| WO2025151752A1 (en) | 2024-01-10 | 2025-07-17 | Xilio Development, Inc. | Masked il-2 cytokines and methods of use thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201808537T4 (tr) * | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| US8054928B2 (en) * | 2005-11-14 | 2011-11-08 | Ati Technologies, Inc. | Programmable preamble system and method |
| EP3543256A1 (en) * | 2009-01-12 | 2019-09-25 | Cytomx Therapeutics Inc. | Modified antibody compositions, methods of making and using thereof |
| US9493578B2 (en) * | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| US20130089554A1 (en) * | 2009-12-29 | 2013-04-11 | Emergent Product Development Seattle, Llc | RON Binding Constructs and Methods of Use Thereof |
| IL299365A (en) * | 2010-05-27 | 2023-02-01 | Genmab As | Monoclonal antibodies against 2HER |
| IN2014CN03887A (cg-RX-API-DMAC7.html) * | 2011-10-27 | 2015-10-16 | Genmab As | |
| WO2013118722A1 (ja) * | 2012-02-06 | 2013-08-15 | トヨタ自動車株式会社 | 硫化物固体電解質材料、電池および硫化物固体電解質材料の製造方法 |
| UY35148A (es) * | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| EP3587448B1 (en) * | 2013-03-15 | 2021-05-19 | Xencor, Inc. | Heterodimeric proteins |
| AP2016009222A0 (en) * | 2013-11-04 | 2016-05-31 | Glenmark Pharmaceuticals Sa | Production of t cell retargeting hetero-dimeric immunoglobulins |
| US20160176969A1 (en) * | 2014-11-26 | 2016-06-23 | Xencor, Inc. | Heterodimeric antibodies including binding to cd8 |
| WO2016087416A1 (en) * | 2014-12-03 | 2016-06-09 | F. Hoffmann-La Roche Ag | Multispecific antibodies |
| WO2016152136A1 (ja) * | 2015-03-20 | 2016-09-29 | 日本電気株式会社 | プラガブル光モジュール、光通信システム及びプラガブル光モジュールの制御方法 |
| CN106883297B (zh) * | 2015-12-16 | 2019-12-13 | 苏州康宁杰瑞生物科技有限公司 | 基于ch3结构域的异二聚体分子、其制备方法及用途 |
| RU2745648C2 (ru) * | 2016-07-19 | 2021-03-30 | Ибентрус, Инк. | Биспецифические белки и способы их получения |
| WO2019014912A1 (zh) * | 2017-07-21 | 2019-01-24 | 赵磊 | 一种异二聚体蛋白及其制备方法 |
| KR20260039804A (ko) * | 2017-12-21 | 2026-03-20 | 아뮤닉스 파마슈티컬스, 인크. | 유리 세그먼트 및 이것을 포함하는 결합 조성물 |
| WO2019148445A1 (en) * | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
| TWI798601B (zh) * | 2020-11-27 | 2023-04-11 | 晶睿通訊股份有限公司 | 地面起伏偵測方法及其監控攝影機 |
| JP7295438B2 (ja) * | 2020-11-30 | 2023-06-21 | 日亜化学工業株式会社 | 面状光源 |
| WO2022170619A1 (en) * | 2021-02-11 | 2022-08-18 | Adagene Pte. Ltd. | Anti-cd3 antibodies and methods of use thereof |
| WO2023193239A1 (en) * | 2022-04-08 | 2023-10-12 | Peter Peizhi Luo | Anti-cd28 antibodies and methods of use thereof |
-
2021
- 2021-01-22 TW TW110102586A patent/TWI920054B/zh active
- 2021-01-22 CN CN202180021100.0A patent/CN115279796A/zh active Pending
- 2021-01-22 KR KR1020227029071A patent/KR20220145833A/ko active Pending
- 2021-01-22 IL IL294878A patent/IL294878A/en unknown
- 2021-01-22 CA CA3165045A patent/CA3165045A1/en active Pending
- 2021-01-22 MX MX2022009101A patent/MX2022009101A/es unknown
- 2021-01-22 EP EP21744991.7A patent/EP4093778A4/en active Pending
- 2021-01-22 JP JP2022544309A patent/JP7710450B2/ja active Active
- 2021-01-22 AU AU2021210482A patent/AU2021210482A1/en active Pending
- 2021-01-22 WO PCT/CN2021/073347 patent/WO2021148006A1/en not_active Ceased
- 2021-01-22 US US17/759,282 patent/US20230124669A1/en active Pending
- 2021-01-22 BR BR112022014574A patent/BR112022014574A2/pt unknown
-
2025
- 2025-07-08 JP JP2025114854A patent/JP2025160226A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025160226A5 (cg-RX-API-DMAC7.html) | ||
| EP2414391B1 (en) | Multispecific antibodies comprising full length antibodies and single chain fab fragments | |
| TWI359027B (en) | Bivalent, bispecific antibodies | |
| JP2022551969A5 (cg-RX-API-DMAC7.html) | ||
| US20220002398A1 (en) | ANTI-oxMIF/ANTI-CD3 ANTIBODY FOR CANCER TREATMENT | |
| JP2019533441A5 (cg-RX-API-DMAC7.html) | ||
| JP2024508671A5 (cg-RX-API-DMAC7.html) | ||
| AU2015329965A1 (en) | Bispecific antibodies against CD3epsilon and ROR1 | |
| JP2023516004A5 (cg-RX-API-DMAC7.html) | ||
| JP2023548529A5 (cg-RX-API-DMAC7.html) | ||
| JP2021507698A5 (cg-RX-API-DMAC7.html) | ||
| JP2026027248A (ja) | 抗原結合分子およびその使用 | |
| JP2023516941A5 (cg-RX-API-DMAC7.html) | ||
| JP2025508317A5 (cg-RX-API-DMAC7.html) | ||
| WO2018237341A1 (en) | A TARGET CELL-DEPENDENT T CELL ENGAGING AND ACTIVATION ASYMMETRIC HETERODIMERIC Fc-ScFv FUSION ANTIBODY FORMAT FOR CANCER THERAPY | |
| WO2025041097A1 (en) | Il-18 polypeptides fused to immune cell antigen specific binding polypeptides and uses thereof | |
| JP2024502095A (ja) | 二重または多重特異性抗体{Bi or Multi-Specific Antibody} | |
| JP2021531757A5 (cg-RX-API-DMAC7.html) | ||
| JP2025511000A5 (cg-RX-API-DMAC7.html) | ||
| WO2025024780A1 (en) | Antibodies that bind gamma-delta t cell receptors for the treatment of cancer | |
| WO2025255480A1 (en) | Tetravalent multispecific binding molecules and methods of use thereof | |
| RU2026104696A (ru) | Антитела, связывающиеся с cd3 | |
| NZ807450A (en) | Antibodies binding to gprc5d | |
| JP2022028645A5 (cg-RX-API-DMAC7.html) | ||
| RU2025130619A (ru) | Биспецифические агонистические антитела к рецептору i типа, подобному рецептору активина а (alk1) |